Table 1 Patients and tumor pathological parameters of the studied population
Patients and tumor characteristics | TWIST1 marker | CD105 marker |
|---|---|---|
Number of CRC samples | 223 | 208 |
Mean age, years (Range) | 59 (20–91) | 59 (25–88) |
  ≤ Mean age | 110 (49.3) | 105 (50.5) |
  > Mean age | 113 (50.7) | 103 (49.5) |
Gender | ||
 Male | 114 (51.1) | 111 (53.4) |
 Female | 109 (48.9) | 97 (46.6) |
 (Male/Female) | 1.04 | 1.14 |
Mean tumor size (cm) | 5 | 5 |
  ≤ Mean | 156 (70.0) | 145 (69.7) |
  > Mean | 67 (30.0) | 63 (30.3) |
Tumor differentiation | ||
 Well | 103 (46.2) | 89 (42.8) |
 Moderate | 104 (46.6) | 107 (51.4) |
 Poor | 16 (7.2) | 12 (5.8) |
TNM stage | ||
 I | 40 (17.9) | 29 (13.9) |
 II | 98 (43.9) | 92 (44.2) |
 III | 79 (35.4) | 80 (38.5) |
 IV | 6 (2.7) | 7 (3.4) |
Vascular invasion (VI) | ||
 Present | 36 (16.1) | 37 (17.8) |
 Absent | 187 (83.9) | 171 (82.2) |
Lymph node invasion (LNI) | ||
 Involved | 82 (36.8) | 83 (39.9) |
 None | 141 (63.2) | 125 (60.1) |
Neural invasion (NI) | ||
 Involved | 47 (21.1) | 57 (27.4) |
 None | 176 (78.9) | 151 (72.6) |
Distant metastasis | ||
 Present | 37 (16.6) | 30 (14.4) |
 Absent | 100 (44.8) | 90 (43.3) |
 Not identified | 86 (38.6) | 88 (42.3) |
Tumor recurrence | ||
 Yes | 42 (18.8) | 36 (17.3) |
 No | 95 (42.6) | 85 (40.9) |
 Not identified | 86 (38.6) | 87 (41.8) |